Observations placeholder
Pegasys
Identifier
016896
Type of Spiritual Experience
Background
A description of the experience
Pegylated interferon alfa-2a (pegylated with a branched 40 kDa PEG chain; commercial name Pegasys) is an antiviral drug ; it has a dual mode of action - both antiviral and on the immune system. The addition of polyethylene glycol to the interferon, through a process known as pegylation, enhances the half-life of the interferon when compared to its native form.
On Jan, 13, 2017 54,565 people reported to have side effects when taking Pegasys. Among them, 194 people (0.36%) have Hallucination
On Dec, 29, 2016 54,565 people reported to have side effects when taking Pegasys. Among them, 739 people (1.35%) have Death